I have created an entire resource with tips and tricks all designed to help you sleep better
Its design is based on the sequence of a natural glucose-dependent insulinotropic polypeptide (GIP) and simultaneously activates the glucagon-like peptide-1 (GLP-1) receptor, hence the name "twincretin." The drug first entered clinical research in 2016, with Eli Lilly initiating a Phase I clinical trial to evaluate its safety, tolerability, pharmacokinetics, and pharmacodynamics in obese or overweight subjects with related comorbidities
Semaglutide is the active ingredient found in FDA-approved medications that are used for lowering blood sugar (glucose) levels in adults with type-2 diabetes and may also be prescribed to support weight loss
Additionally, AstraZeneca picked up the rights to a GLP-1 drug from Eccogene last month for $185 million upfront, aiming to develop and commercialize the therapy for obesity, type 2 diabetes and other cardiometabolic conditions
- We have officially started filming our podcast series We're proud of what we've built, but we're even more excited about what's next
Lisdexamfetamine, marketed as Vyvanse, is a prodrug that converts to dextroamphetamine and helps ADHD by boosting dopamine and norepinephrine